We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRKR
13101
36Kr Holdings
KRKR
$6.26M
$21K ﹤0.01%
906
-459
-34% -$8.61K
LCTX icon
13102
PUT
Lineage Cell Therapeutics
LCTX
$278M
$21K ﹤0.01%
13,400
-500
-4% -$776
NNAVW
13103
DELISTED
NextNav Inc Warrant
NNAVW
$21K ﹤0.01%
11,029
-3,690
-25% -$5.74K
NXGL icon
13104
NexGel
NXGL
$3.51M
$21K ﹤0.01%
10,959
-50,453
-82% -$113K
SOGP
13105
PUT
Sound Group
SOGP
$52.7M
$21K ﹤0.01%
1,370
+270
+25% +$4.01K
TOUR
13106
Tuniu
TOUR
$55.6M
$21K ﹤0.01%
+2,387
New +$26.2K
CSCI
13107
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$21K ﹤0.01%
564
-218
-28% -$7.84K
BTTX
13108
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$21K ﹤0.01%
10,535
-2,178
-17% -$7.53K
IMV
13109
DELISTED
IMV Inc. Common Shares
IMV
$21K ﹤0.01%
1,461
-7,042
-83% -$89.1K
KLDO
13110
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$21K ﹤0.01%
12,667
-21,679
-63% -$38.7K
GMBTW
13111
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$21K ﹤0.01%
31,318
ASTC icon
13112
Astrotech Corp
ASTC
$17.8M
$20K ﹤0.01%
+911
New +$18.7K
BAOS icon
13113
Baosheng Media Group
BAOS
$999K
$20K ﹤0.01%
+1,772
New +$24.2K
ENVB icon
13114
Enveric Biosciences
ENVB
$6.24M
$20K ﹤0.01%
6
-11
-65% -$48.6K
EVGN icon
13115
Evogene
EVGN
$7.26M
$20K ﹤0.01%
1,524
-8,546
-85% -$115K
GLMD icon
13116
Galmed Pharmaceuticals
GLMD
$4.97M
$20K ﹤0.01%
+70
New +$19.8K
IZEA icon
13117
CALL
IZEA Worldwide
IZEA
$61.3M
$20K ﹤0.01%
2,950
-8,500
-74% -$39.8K
MDWD icon
13118
CALL
MediWound
MDWD
$185M
$20K ﹤0.01%
+1,457
New +$23.6K
MLSS icon
13119
Milestone Scientific
MLSS
$42.6M
$20K ﹤0.01%
12,949
-29,303
-69% -$42.8K
NERV icon
13120
PUT
Minerva Neurosciences
NERV
$199M
$20K ﹤0.01%
2,963
+88
+3% +$540
SSY
13121
DELISTED
SunLink Health Systems
SSY
$20K ﹤0.01%
+13,929
New +$19.6K
UXIN
13122
CALL
Uxin Ltd
UXIN
$282M
$20K ﹤0.01%
195
-61
-24% -$6.96K
AAU
13123
DELISTED
Almaden Minerals Ltd
AAU
$20K ﹤0.01%
+55,944
New +$18K
ACGN
13124
DELISTED
Aceragen Inc
ACGN
$20K ﹤0.01%
2,398
-10,074
-81% -$91.1K
PHCF
13125
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$20K ﹤0.01%
3,930
+2,250
+134% +$13.7K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.